Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-110921
Filing Date
2024-10-01
Accepted
2024-10-01 17:04:21
Documents
1
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3965
  Complete submission text file 0000950170-24-110921.txt   5390
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address
Cassella James V (Reporting) CIK: 0001353528 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38886 | Film No.: 241344193

Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)